Promotes Prahlad Singh to lead newly created role
WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 10, 2018--
PerkinElmer,
Inc. (NYSE:PKI), a global leader committed to innovating for a
healthier world, today announced that its board of directors has named
Prahlad Singh president and chief operating officer, effective January
1, 2019. In his expanded position, Dr. Singh will have responsibility
for both the Discovery and Analytical Solutions (DAS) and Diagnostics
operating divisions of the Company. This change is being made to better
facilitate synergies across the businesses to identify incremental
growth opportunities, create operating efficiencies, and most
importantly, accelerate the pace of innovation across the Company. Dr.
Singh, along with the leaders of the Company’s corporate functions, will
continue to report to Robert F. Friel, PerkinElmer’s chairman and chief
executive officer.
“It is clear that technologies, applications, and customer needs are
converging across DAS and Diagnostics as our customers’ businesses
evolve and the lines between therapeutics, diagnostics, food, and
digital health are intersecting,” said Friel. “The opportunities for DAS
to become an enabler of the sciences of Diagnostics, and vice-versa,
continue to grow. Prahlad’s track record of consistently driving strong
results operationally, commercially and strategically makes him well
qualified to take on this important role. I look forward to working with
him as he helps both the Diagnostics and DAS businesses better innovate
breakthrough solutions and exceptionally serve our customers, ultimately
driving greater value across our markets.”
Dr. Singh joined PerkinElmer in 2014 as president of the Diagnostics
business. He was elected an officer of PerkinElmer in 2016 and executive
vice president in March 2018. Dr. Singh served as general manager of GE
Healthcare’s Women’s Health Business, responsible for the mammography
and bone densitometry businesses. Before that, Dr. Singh held senior
executive level roles in strategy, business development and M&A at both
GE and Philips Healthcare. From 1995 to 2007, he held leadership roles
of increasing responsibility at DuPont Pharmaceuticals and subsequently
Bristol Myers Squibb Medical Imaging which included managing the Asia
Pacific and Middle East regions.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on innovating for a
healthier world. The Company reported revenue of approximately $2.3
billion in 2017, has about 11,000 employees serving customers in more
than 150 countries, and is a component of the S&P 500 Index. Additional
information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181210005183/en/
Source: PerkinElmer, Inc.
Investor Relations
Tommy J. Thomas, 781-663-5889
tommy.thomas@perkinelmer.com
Media
Relations
Brian Willinsky, 781-663-5728
brian.willinsky@perkinelmer.com